Switch theme
Sign up to access all valuation multiples
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue.
1997
4.1K+
LTM Revenue $794M
LTM EBITDA $271M
$4.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mouwasat has a last 12-month revenue of $794M and a last 12-month EBITDA of $271M.
In the most recent fiscal year, Mouwasat achieved revenue of $768M and an EBITDA of $260M.
Mouwasat expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Mouwasat valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $722M | $768M | XXX | XXX | XXX |
| Gross Profit | $293M | $350M | XXX | XXX | XXX |
| Gross Margin | 41% | 46% | XXX | XXX | XXX |
| EBITDA | $266M | $260M | XXX | XXX | XXX |
| EBITDA Margin | 37% | 34% | XXX | XXX | XXX |
| Net Profit | $160M | $176M | XXX | XXX | XXX |
| Net Margin | 22% | 23% | XXX | XXX | XXX |
| Net Debt | $192M | $191M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Mouwasat's stock price is SAR 73 (or $20).
Mouwasat has current market cap of SAR 14.7B (or $3.9B), and EV of SAR 14.9B (or $4.0B).
See Mouwasat trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.0B | $3.9B | XXX | XXX | XXX | XXX | $0.91 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Mouwasat has market cap of $3.9B and EV of $4.0B.
Mouwasat's trades at 5.0x LTM EV/Revenue multiple, and 14.7x LTM EBITDA.
Analysts estimate Mouwasat's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Mouwasat and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $4.0B | XXX | XXX | XXX |
| EV/Revenue | 5.2x | XXX | XXX | XXX |
| EV/EBITDA | 15.3x | XXX | XXX | XXX |
| P/E | 22.7x | XXX | XXX | XXX |
| P/E/Growth | 1.9x | XXX | XXX | XXX |
| EV/FCF | 18.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMouwasat's NTM/LTM revenue growth is 11%
Mouwasat's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $33K for the same period.
Over next 12 months, Mouwasat's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Mouwasat's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Mouwasat and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -2% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 45% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $33K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 18% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mouwasat acquired XXX companies to date.
Last acquisition by Mouwasat was XXXXXXXX, XXXXX XXXXX XXXXXX . Mouwasat acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Mouwasat founded? | Mouwasat was founded in 1997. |
| Where is Mouwasat headquartered? | Mouwasat is headquartered in Saudi Arabia. |
| How many employees does Mouwasat have? | As of today, Mouwasat has 4.1K+ employees. |
| Who is the CEO of Mouwasat? | Mouwasat's CEO is Mr. Nasser Sultan Fahed Al-Subaie. |
| Is Mouwasat publicy listed? | Yes, Mouwasat is a public company listed on SAU. |
| What is the stock symbol of Mouwasat? | Mouwasat trades under 4002 ticker. |
| When did Mouwasat go public? | Mouwasat went public in 2009. |
| Who are competitors of Mouwasat? | Similar companies to Mouwasat include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Mouwasat? | Mouwasat's current market cap is $3.9B |
| What is the current revenue of Mouwasat? | Mouwasat's last 12-month revenue is $794M. |
| What is the current EBITDA of Mouwasat? | Mouwasat's last 12-month EBITDA is $271M. |
| What is the current EV/Revenue multiple of Mouwasat? | Current revenue multiple of Mouwasat is 5.0x. |
| What is the current EV/EBITDA multiple of Mouwasat? | Current EBITDA multiple of Mouwasat is 14.7x. |
| What is the current revenue growth of Mouwasat? | Mouwasat revenue growth between 2023 and 2024 was 6%. |
| Is Mouwasat profitable? | Yes, Mouwasat is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
